🔬 Exciting Advancement in Nosocomial Pathogen Research! 🦠 BRIC-Translational Health Science and Technology Institute (THSTI) has successfully sequenced the genome of an extensively drug-resistant (XDR) Acinetobacter baumannii strain, isolated from a sepsis patient. Conducted at the GeHuMic facility under the DBT-funded multi-institutional sepsis program, this research provides crucial information on the resistance mechanisms of this nosocomial pathogen, a leading cause of healthcare-associated infections. With antimicrobial resistance on the rise, especially in critical care settings, insights gained from this work are essential for informing effective treatment strategies and improving patient outcomes. Kudos to our dedicated research teams at BRIC-THSTI for pushing boundaries in #AMR and #SepsisResearch! #OneDayOneGenome #AntibioticResistance #Genomics #ResearchAndDevelopment #PublicHealth #OneHealth BRIC-National Institute of Biomedical Genomics Rajesh Gokhale
